The duration of hormone therapy depends entirely on why you’re taking it. Menopause hormone therapy has no fixed time limit and can last years or even decades with regular check-ins. Breast cancer hormone therapy typically runs 5 to 10 years. Gender-affirming hormone therapy is usually lifelong. And thyroid hormone replacement, once started, is almost always permanent. Here’s what to expect for each type and what happens when you stop.
Menopause Hormone Therapy
There is no universal rule for how long menopause hormone therapy should last. The old “five-year rule” that many doctors once followed has largely been abandoned. Current guidelines from the North American Menopause Society recommend individualizing treatment duration and reevaluating periodically rather than imposing a hard cutoff. For women under 60, or those who started therapy within 10 years of menopause, the benefits generally outweigh the risks for as long as symptoms persist.
In practice, many women use hormone therapy for 3 to 5 years for hot flashes and night sweats, which tend to fade over time. But some women have symptoms that last a decade or longer, and for them, continuing therapy is considered safe at the lowest effective dose with regular follow-up every 1 to 2 years. There is no medical requirement to stop at age 60 or 65. Instead, your doctor may suggest trying a lower dose, switching to a patch (which carries lower clot risk than pills), or doing a trial pause to see if symptoms have resolved on their own.
Women who go through early menopause, whether naturally or from surgery, are a special case. Because losing estrogen early raises the risk of heart disease and diabetes, they’re generally advised to stay on hormone therapy at least until the average age of natural menopause, around 50 to 52.
When Symptom Relief Kicks In
If you’ve just started, expect a gradual ramp-up. In the first few weeks, hot flashes may become slightly milder and nighttime waking may ease. By months 2 to 3, most women notice a clear shift: hot flashes are far less frequent or intense, and sleep improves substantially. Full stabilization of mood, energy, and vaginal symptoms can take 3 to 6 months.
What Happens When You Stop
About 75% of women experience a return of hot flashes after discontinuing menopause hormone therapy. Sleep disruption comes back for roughly 57% to 74% of women, and mood swings or depression return in about a third to half. Vaginal dryness affects around 28% to 44%. These numbers explain why stopping can be difficult: in one study, women who struggled to quit reported higher rates of insomnia, fatigue, and mood changes compared to those who successfully stopped.
Whether you should taper or stop abruptly is surprisingly unclear. Research has produced mixed results. Tapering tends to produce fewer rebound symptoms in the short term, but women who taper are actually twice as likely to resume therapy compared to those who stop cold turkey. One possible explanation is that tapering keeps the body partially dependent on external hormones for longer, making the final step harder. Either approach is reasonable, and neither has been shown to be clearly superior.
Bone Density After Stopping
Bone loss accelerates within the first 2 years after stopping hormone therapy, at a rate of about 1.6% per year in the spine. That’s nearly identical to the rapid bone loss women experience in the first years after menopause itself. After those initial 2 years, the rate slows considerably. The good news: women who used hormone therapy for years still had measurably higher bone density 3 years after stopping compared to where they started before treatment, suggesting a lasting (though diminishing) benefit.
Breast Cancer Hormone Therapy
For estrogen-receptor-positive breast cancer, the standard course of hormone-blocking therapy is 5 years. This is a different kind of hormone therapy from menopause treatment. Rather than replacing estrogen, it suppresses or blocks estrogen to starve cancer cells. Five years of this treatment reduces the risk of cancer recurrence in the first decade by about 40% with one class of drug and 50% with another, with little additional benefit beyond that window.
Some women with higher-risk cancers are offered extended therapy lasting 7 to 10 years total. A large meta-analysis of over 22,000 postmenopausal women found that extending treatment beyond 5 years provides a modest additional reduction in recurrence. Whether extension is worthwhile depends on your individual recurrence risk weighed against side effects like joint pain, bone thinning, and hot flashes that persist for the duration of treatment.
Prostate Cancer Hormone Therapy
Hormone therapy for prostate cancer, which suppresses testosterone, varies widely based on how aggressive the cancer is. For men with intermediate-risk disease involving a single risk factor, hormone therapy may not be needed at all alongside radiation. With two or more intermediate-risk factors, 6 months is a common duration. For high-risk prostate cancer, guidelines have traditionally recommended 18 to 36 months.
Recent evidence from a meta-analysis of 13 clinical trials suggests those longer durations may be more than some patients need. The data showed that improvements in survival and cancer control followed a curve of diminishing returns, with reduced benefits beyond 9 to 12 months for many patients. This is prompting some oncologists to consider shorter courses for select patients, though decisions still depend on individual risk profiles.
Gender-Affirming Hormone Therapy
Gender-affirming hormone therapy is typically lifelong for people who choose to continue it. Unlike menopause therapy, which addresses a temporary transition, gender-affirming hormones maintain the physical characteristics that align with a person’s gender identity. Stopping would gradually reverse some (though not all) of the changes.
The physical effects unfold on different timelines depending on the direction of treatment. For those taking estrogen, breast growth and body fat redistribution reach their maximum over 2 to 5 years. Decreased muscle mass peaks at 1 to 2 years. Reduction in body hair takes more than 3 years to fully develop. Voice pitch does not change with estrogen alone.
For those taking testosterone, voice deepening, menstrual cessation, and clitoral changes typically reach their maximum within 1 to 2 years. Facial and body hair growth, along with any scalp hair thinning, continues to develop for more than 5 years. Muscle mass and fat redistribution take 2 to 5 years to fully settle. Some of these changes, like voice deepening and facial hair growth, are permanent even if testosterone is later stopped. Others, like muscle mass and fat distribution, would gradually reverse.
Thyroid Hormone Replacement
For hypothyroidism, hormone replacement is almost always lifelong. The thyroid gland in most cases does not recover its ability to produce adequate hormones, whether the cause is autoimmune disease, surgical removal, or radiation treatment. Stopping thyroid medication leads to a return of symptoms like fatigue, weight gain, cold sensitivity, and cognitive sluggishness, typically within weeks. Doses may be adjusted over time as your body’s needs change with age, weight, or pregnancy, but the therapy itself rarely ends.